Denali Therapeutics
DNLI
#3772
Rank
โ‚ฌ3.31 B
Marketcap
20,71ย โ‚ฌ
Share price
-2.72%
Change (1 day)
54.74%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2026 (TTM): -2,46ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,49ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,56ย โ‚ฌ a decrease over its 2024 EPS that were of -2,22ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,46ย โ‚ฌ-4.06%
2025-2,56ย โ‚ฌ15.56%
2024-2,22ย โ‚ฌ147.12%
2023-0,90ย โ‚ฌ-60%
2022-2,24ย โ‚ฌ8.79%
2021-2,06ย โ‚ฌ-712.82%
20200,34ย โ‚ฌ-118.93%
2019-1,78ย โ‚ฌ402.44%
2018-0,35ย โ‚ฌ-88.89%
2017-3,18ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Organovo
ONVO
-9,94ย โ‚ฌ 300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,13ย โ‚ฌ 146.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-0,47ย โ‚ฌ-81.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-1,32ย โ‚ฌ-46.87% Jersey